CCIA
WGS icon

Campbell & Co Investment Adviser’s GeneDx Holdings WGS Stock Holding History

Campbell & Co Investment Adviser’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,206
Closed -$204K – 1413
2025
Q2 		$204K Buy
+2,206
New +$173K 0.01% 1054

Other funds holding WGS

CM
Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
SPPAM
Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Campbell & Co Investment Adviser's WGS Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of GeneDx Holdings (WGS) in Q3 2025, closing a stake of 2,206 shares — an estimated $204K sold.

Campbell & Co Investment Adviser first reported a position in WGS in Q2 2025 and held it in 1 quarter. The position peaked at $204K in Q2 2025. 268 funds tracked by Wall St. Rank hold WGS as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining GeneDx Holdings position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 2,206 GeneDx Holdings shares in Q3 2025, an estimated $204K.
  • Campbell & Co Investment Adviser first reported a position in GeneDx Holdings in Q2 2025 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's GeneDx Holdings position peaked at $204K in Q2 2025.
  • 268 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.